{"nct_id":"NCT02992483","title":"Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma","status":"COMPLETED","status_verified_date":"2021-07","start_date":"2017-07-12","start_date_type":"ACTUAL","primary_completion_date":"2019-06-07","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}